Structure and apoptotic function of p73

키워드

참고문헌 (61)

1. Dötsch V, "p63 and p73, the ancestors of p53", Cold Spring Harb Perspect Biol, 2, pp.a004887~ (2010)
2. Cutruzzola F, "p73 keeps metabolic control in balance", Cell Cycle, 13, pp.179~180 (2014)
3. Inoue S, "TAp73 is required for spermatogenesis and the maintenance of male fertility", Proc Natl Acad Sci U S A, 111, pp.1843~1848 (2014)
4. Murray-Zmijewski F, "p53", p63, Cell Death Differ, pp.2006, 13[DOI]
5. Melino G, "p73 : Friend or foe in tumorigenesis", Nat Rev Cancer, 2, pp.605~615 (2002)
6. Munarriz E, "Calpain cleavage regulates the protein stability of p73", Biochem Biophys Res Commun, 333, pp.954~960 (2005)
7. Asher G, "A mechanism of ubiquitin-independent proteasomal degradation of the tumor suppressors p53 and p73", Genes Dev, 19, pp.316~321 (2005)
8. Rossi M, "The ubiquitin-protein ligase Itch regulates p73 stability", EMBO J, 24, pp.836~848 (2005)
9. Oberst A, "The Nedd4-binding partner 1(N4BP1)protein is an inhibitor of the E3 ligase Itch", Proc Natl Acad Sci U S A, 104, pp.11280~11285 (2007)
10. Levy D, "The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73", Cell Death Differ, 14, pp.743~751 (2007)
11. Costanzo A, "DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes", Mol Cell, 9, pp.175~186 (2002)
12. Mantovani F, "Pin1 links the activities of c-Abl and p300 in regulating p73function", Mol Cell, 14, pp.625~636 (2004)
13. Sayan BS, "Differential control of TAp73 and DeltaNp73 protein stability by the ring finger ubiquitin ligase PIR2", Proc Natl Acad Sci U S A, 107, pp.12877~12882 (2010)
14. Toh WH, "c-Jun regulates the stability and activity of the p53 homologue, p73", J Biol Chem, 279, pp.44713~44722 (2004)
15. Danovi SA, "Yes-associated protein(YAP)is a critical mediator of c-Jun-dependent apoptosis", Cell Death Differ, 15, pp.217~219 (2008)
16. Dulloo I, "The antiapoptotic DeltaNp73 is degraded in a c-Jun-dependent manner upon genotoxic stress through the antizyme-mediated pathway", Proc Natl Acad Sci U S A, 107, pp.4902~4907 (2010)
17. Ramadan S, "p73 induces apoptosis by different mechanisms", Biochem Biophys Res Commun, 331, pp.713~717 (2005)
18. Zaika AI, "DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors", J Exp Med, 196, pp.765~780 (2002)
19. Chi SG, "Elevated and biallelic expression of p73 is associated withprogression of human bladder cancer", Cancer Res, 59, pp.2791~2793 (1999)
20. Moll UM, "p63 and p73: roles in development and tumor formation", Mol Cancer Res, 2, pp.371~386 (2004)
21. Casciano I, "Expression of DeltaNp73 is a molecular marker for adverse outcome in neuroblastoma patients", Cell Death Differ, 9, pp.246~251 (2002)
22. p53-related protein that can induce apoptosis, "Nature", 1997, 191~194
23. Miyashita T, "Tumor suppressor p53 is a direct transcriptional activator of the human bax gene", Cell, 80, pp.293~299 (1995)
24. Nakano K, "PUMA, a novel proapoptotic gene, is induced by p53", Mol Cell, 7, pp.683~694 (2001)
25. Oda E, "Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis", Science, 288, pp.1053~1058 (2000)
26. Müller M, "p53 activates the CD95(APO-1", Fas)gene in response to DNA damage by anticancer drugs, 1998, pp.188, 2033~2045
27. Mihara M, "p53 has a direct apoptogenic role at the mitochondria", Mol Cell, 11, pp.577~590 (2003)
28. Chipuk JE, "Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis", Science, 303, pp.1010~1014 (2004)
29. Chipuk JE, "PUMA couples the nuclear and cytoplasmic proapoptotic function of p53", Science, 309, pp.1732~1735 (2005)
30. 지승욱, "Structural insights into the transcription-independent apoptotic pathway of p53", BMB Reports, 47(3), pp.167~172 (2014), 생화학분자생물학회
31. Chipuk JE, "Mitochondrial outer membrane permeabilization during apoptosis:the innocent bystander scenario", Cell Death Differ, 13, pp.1396~1402 (2006)
32. Ha JH, "Dual-site interactions of p53 protein transactivation domain with anti-apoptotic Bcl-2 family proteins reveal a highly convergent mechanism of divergent p53 pathways", J Biol Chem, 288, pp.7387~7398 (2013)
33. Ha JH, "Molecular mimicry-based repositioning of nutlin-3 to anti-apoptotic Bcl-2family proteins", J Am Chem Soc, 133, pp.1244~1247 (2011)
34. Dong-Hwa Lee, "A Conserved Mechanism for Binding of p53 DNA-Binding Domain and Anti-Apoptotic Bcl-2 Family Proteins", Molecules and Cells, 37(3), pp.264~269 (2014), 한국분자세포생물학회[DOI]
35. Bell S, "p53 contains large unstructured regions in its native state", J Mol Biol, 322, pp.917~927 (2002)
36. Burge S, "Molecular basis of the interactions between the p73 N terminus and p300: effects on transactivation and modulation by phosphorylation", Proc Natl Acad Sci U S A, 106, pp.3142~3147 (2009)
37. Liu G, "The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300", CREBbinding protein, 2003, pp.278, 17557~17565
38. Shin JS, "Structural convergence of unstructured p53 family transactivation domains in MDM2 recognition", Cell Cycle, 14, pp.533~543 (2015)
39. Kussie PH, "Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain", Science, 274, pp.948~953 (1996)
40. Canning P, "Structural basis for ASPP2 recognition by the tumor suppressor p73", J Mol Biol, 423, pp.515~527 (2012)
41. Ethayathulla AS, "Structure of p73 DNA-binding domain tetramer modulates p73 transactivation", Proc Natl Acad Sci U S A, 109, pp.6066~6071 (2012)
42. Bullock AN, "Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy", Oncogene, 19, pp.1245~1256 (2000)
43. Joerger AC, "Structural evolution of p53, p63, and p73: implication for heterotetramer formation", Proc Natl Acad Sci U S A, 106, pp.17705~17710 (2009)
44. Chi SW, "Solution structure of a conserved C-terminal domain of p73 with structural homology to the SAM domain", EMBO J, 18, pp.4438~4445 (1999)
45. Thanos CD, "Oligomeric structure of the human EphB2 receptor SAM domain", Science, 283, pp.833~836 (1999)
46. Stapleton D, "The crystal structure of an Eph receptor SAM domain reveals a mechanism for modular dimerization", Nat Struct Biol, 6, pp.44~49 (1999)
47. Chipuk JE, "The BCL-2 family reunion", Mol Cell, 37, pp.299~310 (2010)
48. Melino G, "p73Induces apoptosis via PUMA transactivation and Bax mitochondrial translocation", J Biol Chem, 279, pp.8076~8083 (2004)
49. John K, "GRAMD4mimics p53 and mediates the apoptotic function of p73 at mitochondria", Cell Death Differ, 18, pp.874~886 (2011)
50. Deng Y, "Peg3", Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria, 2000, pp.97, 12050~12055
51. Taebunpakul P, "Apoptin induces apoptosis by changing the equilibrium between the stability of TAp73 and DeltaNp73 isoforms through ubiquitin ligase PIR2", Apoptosis, 17, pp.762~776 (2012)
52. Schilling T, "Active transcription of the human FAS", CD95, Biochem Biophys Res Commun, pp.2009, 387[DOI]
53. Terrasson J, "p73-dependent apoptosis through death receptor: impairment by human cytomegalovirus infection", Cancer Res, 65, pp.2787~2794 (2005)
54. Aqeilan RI, "Functional association between Wwox tumor suppressor protein and p73, a p53 homolog", Proc Natl Acad Sci U S A, 101, pp.4401~4406 (2004)
55. Inoue T, "Nuclear import and export signals in control of the p53-related protein p73", J Biol Chem, 277, pp.15053~15060 (2002)
56. Liu T, "Cooperative role of RanBP9 and P73 in mitochondriamediated apoptosis", Cell Death Dis, 4, pp.e476~ (2013)
57. Atabakhsh E, "RanBPM has proapoptotic activities that regulate cell death pathways in response to DNA damage", Mol Cancer Res, 7, pp.1962~1972 (2009)
58. Kramer S, "Protein stability and function of p73 are modulated by a physical interaction with RanBPM in mammalian cultured cells", Oncogene, 24, pp.938~944 (2005)
59. Rao MA, "RanBPM, a nuclear protein that interacts with and regulates transcriptional activity of androgen receptor and glucocorticoid receptor", J Biol Chem, 277, pp.48020~48027 (2002)
60. Sayan AE, "P73 and caspase-cleaved p73 fragments localize to mitochondria and augment TRAIL-induced apoptosis", Oncogene, 27, pp.4363~4372 (2008)
61. Chang NS, "Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity", J Biol Chem, 276, pp.3361~3370 (2001)

관련 논문AI추천